nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—Rifampicin—leprosy	0.14	0.165	CbGbCtD
Efavirenz—CYP2C19—Thalidomide—leprosy	0.092	0.108	CbGbCtD
Efavirenz—CYP2C19—Rifampicin—leprosy	0.0891	0.105	CbGbCtD
Efavirenz—CYP1A2—Thalidomide—leprosy	0.0849	0.0996	CbGbCtD
Efavirenz—CYP1A2—Rifampicin—leprosy	0.0822	0.0965	CbGbCtD
Efavirenz—CYP2C9—Thalidomide—leprosy	0.0765	0.0898	CbGbCtD
Efavirenz—CYP2C9—Rifampicin—leprosy	0.0741	0.0869	CbGbCtD
Efavirenz—CYP2C19—Dapsone—leprosy	0.0735	0.0863	CbGbCtD
Efavirenz—CYP2C9—Dapsone—leprosy	0.0611	0.0718	CbGbCtD
Efavirenz—CYP3A4—Rifampicin—leprosy	0.0431	0.0506	CbGbCtD
Efavirenz—CYP3A4—Dapsone—leprosy	0.0355	0.0417	CbGbCtD
Efavirenz—Teratogenicity—Thalidomide—leprosy	0.00592	0.04	CcSEcCtD
Efavirenz—Suicide attempt—Dapsone—leprosy	0.00427	0.0289	CcSEcCtD
Efavirenz—Autoimmune disorder—Thalidomide—leprosy	0.00372	0.0251	CcSEcCtD
Efavirenz—Erythema nodosum—Thalidomide—leprosy	0.00287	0.0194	CcSEcCtD
Efavirenz—Proteinuria—Dapsone—leprosy	0.00276	0.0186	CcSEcCtD
Efavirenz—Protein urine present—Dapsone—leprosy	0.00272	0.0184	CcSEcCtD
Efavirenz—Skin exfoliation—Dapsone—leprosy	0.00231	0.0156	CcSEcCtD
Efavirenz—Vesiculobullous rash—Thalidomide—leprosy	0.00221	0.015	CcSEcCtD
Efavirenz—Suicide attempt—Thalidomide—leprosy	0.00219	0.0148	CcSEcCtD
Efavirenz—Enlargement abdomen—Thalidomide—leprosy	0.00206	0.0139	CcSEcCtD
Efavirenz—Nail disorder—Thalidomide—leprosy	0.00191	0.0129	CcSEcCtD
Efavirenz—Neuralgia—Thalidomide—leprosy	0.00179	0.0121	CcSEcCtD
Efavirenz—Hepatomegaly—Thalidomide—leprosy	0.00175	0.0118	CcSEcCtD
Efavirenz—Psychotic disorder—Dapsone—leprosy	0.00172	0.0116	CcSEcCtD
Efavirenz—Stupor—Thalidomide—leprosy	0.00166	0.0112	CcSEcCtD
Efavirenz—Neuritis—Thalidomide—leprosy	0.00166	0.0112	CcSEcCtD
Efavirenz—Nasopharyngitis—Dapsone—leprosy	0.00157	0.0106	CcSEcCtD
Efavirenz—Rash pustular—Thalidomide—leprosy	0.00156	0.0105	CcSEcCtD
Efavirenz—Muscular weakness—Dapsone—leprosy	0.00155	0.0105	CcSEcCtD
Efavirenz—Endocrine disorder—Thalidomide—leprosy	0.0015	0.0101	CcSEcCtD
Efavirenz—Pancreatitis—Dapsone—leprosy	0.00149	0.0101	CcSEcCtD
Efavirenz—Apnoea—Thalidomide—leprosy	0.00146	0.00989	CcSEcCtD
Efavirenz—Proteinuria—Thalidomide—leprosy	0.00141	0.00954	CcSEcCtD
Efavirenz—Protein urine present—Thalidomide—leprosy	0.00139	0.00941	CcSEcCtD
Efavirenz—Photosensitivity reaction—Dapsone—leprosy	0.00139	0.00938	CcSEcCtD
Efavirenz—Skin discolouration—Thalidomide—leprosy	0.00137	0.00928	CcSEcCtD
Efavirenz—Thinking abnormal—Thalidomide—leprosy	0.00136	0.00916	CcSEcCtD
Efavirenz—Neuropathy peripheral—Dapsone—leprosy	0.00133	0.00898	CcSEcCtD
Efavirenz—Hypercholesterolaemia—Thalidomide—leprosy	0.00131	0.00886	CcSEcCtD
Efavirenz—Creatinine increased—Thalidomide—leprosy	0.0013	0.00881	CcSEcCtD
Efavirenz—Bone pain—Thalidomide—leprosy	0.0013	0.00875	CcSEcCtD
Efavirenz—Sinusitis—Dapsone—leprosy	0.00127	0.00859	CcSEcCtD
Efavirenz—Coordination abnormal—Thalidomide—leprosy	0.00126	0.00854	CcSEcCtD
Efavirenz—Depressed level of consciousness—Thalidomide—leprosy	0.0012	0.0081	CcSEcCtD
Efavirenz—Skin exfoliation—Thalidomide—leprosy	0.00119	0.008	CcSEcCtD
Efavirenz—Neuropathy—Thalidomide—leprosy	0.00117	0.00787	CcSEcCtD
Efavirenz—Tinnitus—Dapsone—leprosy	0.00114	0.00767	CcSEcCtD
Efavirenz—Rash maculo-papular—Thalidomide—leprosy	0.00113	0.00762	CcSEcCtD
Efavirenz—Lightheadedness—Thalidomide—leprosy	0.00111	0.0075	CcSEcCtD
Efavirenz—Gynaecomastia—Thalidomide—leprosy	0.00111	0.0075	CcSEcCtD
Efavirenz—Mental disability—Thalidomide—leprosy	0.00108	0.00728	CcSEcCtD
Efavirenz—Euphoric mood—Thalidomide—leprosy	0.00107	0.0072	CcSEcCtD
Efavirenz—Erythema—Dapsone—leprosy	0.00106	0.00716	CcSEcCtD
Efavirenz—Thrombophlebitis—Thalidomide—leprosy	0.00104	0.00703	CcSEcCtD
Efavirenz—Eczema—Thalidomide—leprosy	0.001	0.00677	CcSEcCtD
Efavirenz—Vision blurred—Dapsone—leprosy	0.000999	0.00675	CcSEcCtD
Efavirenz—Cardiac failure congestive—Thalidomide—leprosy	0.000994	0.00671	CcSEcCtD
Efavirenz—Renal failure acute—Thalidomide—leprosy	0.000976	0.00659	CcSEcCtD
Efavirenz—Amnesia—Thalidomide—leprosy	0.000959	0.00648	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Thalidomide—leprosy	0.000955	0.00645	CcSEcCtD
Efavirenz—Vertigo—Dapsone—leprosy	0.000952	0.00643	CcSEcCtD
Efavirenz—Dermatitis bullous—Thalidomide—leprosy	0.000943	0.00637	CcSEcCtD
Efavirenz—Cough—Dapsone—leprosy	0.000925	0.00625	CcSEcCtD
Efavirenz—Diplopia—Thalidomide—leprosy	0.000901	0.00609	CcSEcCtD
Efavirenz—Affect lability—Thalidomide—leprosy	0.000887	0.00599	CcSEcCtD
Efavirenz—Migraine—Thalidomide—leprosy	0.000887	0.00599	CcSEcCtD
Efavirenz—Psychotic disorder—Thalidomide—leprosy	0.00088	0.00594	CcSEcCtD
Efavirenz—Mood swings—Thalidomide—leprosy	0.000854	0.00577	CcSEcCtD
Efavirenz—Ataxia—Thalidomide—leprosy	0.000847	0.00572	CcSEcCtD
Efavirenz—Tachycardia—Dapsone—leprosy	0.000844	0.0057	CcSEcCtD
Efavirenz—Blood creatinine increased—Thalidomide—leprosy	0.000844	0.0057	CcSEcCtD
Efavirenz—Hypokalaemia—Thalidomide—leprosy	0.00082	0.00554	CcSEcCtD
Efavirenz—Breast disorder—Thalidomide—leprosy	0.000814	0.0055	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000811	0.00548	CcSEcCtD
Efavirenz—Muscular weakness—Thalidomide—leprosy	0.000795	0.00537	CcSEcCtD
Efavirenz—Abdominal distension—Thalidomide—leprosy	0.000784	0.0053	CcSEcCtD
Efavirenz—Insomnia—Dapsone—leprosy	0.000782	0.00528	CcSEcCtD
Efavirenz—Pancreatitis—Thalidomide—leprosy	0.000764	0.00516	CcSEcCtD
Efavirenz—Pancytopenia—Thalidomide—leprosy	0.00074	0.005	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Thalidomide—leprosy	0.000724	0.00489	CcSEcCtD
Efavirenz—Photosensitivity reaction—Thalidomide—leprosy	0.000711	0.0048	CcSEcCtD
Efavirenz—Gastrointestinal pain—Dapsone—leprosy	0.000707	0.00478	CcSEcCtD
Efavirenz—Hyperglycaemia—Thalidomide—leprosy	0.000702	0.00474	CcSEcCtD
Efavirenz—Pneumonia—Thalidomide—leprosy	0.000698	0.00472	CcSEcCtD
Efavirenz—Infestation NOS—Thalidomide—leprosy	0.000694	0.00469	CcSEcCtD
Efavirenz—Drowsiness—Thalidomide—leprosy	0.000694	0.00469	CcSEcCtD
Efavirenz—Infestation—Thalidomide—leprosy	0.000694	0.00469	CcSEcCtD
Efavirenz—Depression—Thalidomide—leprosy	0.000692	0.00468	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000688	0.00465	CcSEcCtD
Efavirenz—Abdominal pain—Dapsone—leprosy	0.000684	0.00462	CcSEcCtD
Efavirenz—Body temperature increased—Dapsone—leprosy	0.000684	0.00462	CcSEcCtD
Efavirenz—Renal failure—Thalidomide—leprosy	0.000683	0.00461	CcSEcCtD
Efavirenz—Neuropathy peripheral—Thalidomide—leprosy	0.000681	0.0046	CcSEcCtD
Efavirenz—Sweating—Thalidomide—leprosy	0.000666	0.0045	CcSEcCtD
Efavirenz—Haematuria—Thalidomide—leprosy	0.000662	0.00447	CcSEcCtD
Efavirenz—Sinusitis—Thalidomide—leprosy	0.000651	0.0044	CcSEcCtD
Efavirenz—Rhinitis—Thalidomide—leprosy	0.000625	0.00422	CcSEcCtD
Efavirenz—Hepatitis—Thalidomide—leprosy	0.000623	0.00421	CcSEcCtD
Efavirenz—Hypoaesthesia—Thalidomide—leprosy	0.00062	0.00419	CcSEcCtD
Efavirenz—Urinary tract disorder—Thalidomide—leprosy	0.000616	0.00416	CcSEcCtD
Efavirenz—Oedema peripheral—Thalidomide—leprosy	0.000614	0.00415	CcSEcCtD
Efavirenz—Urethral disorder—Thalidomide—leprosy	0.000611	0.00413	CcSEcCtD
Efavirenz—Visual impairment—Thalidomide—leprosy	0.000601	0.00406	CcSEcCtD
Efavirenz—Erythema multiforme—Thalidomide—leprosy	0.000589	0.00398	CcSEcCtD
Efavirenz—Eye disorder—Thalidomide—leprosy	0.000583	0.00393	CcSEcCtD
Efavirenz—Tinnitus—Thalidomide—leprosy	0.000581	0.00393	CcSEcCtD
Efavirenz—Cardiac disorder—Thalidomide—leprosy	0.000579	0.00391	CcSEcCtD
Efavirenz—Angiopathy—Thalidomide—leprosy	0.000566	0.00382	CcSEcCtD
Efavirenz—Immune system disorder—Thalidomide—leprosy	0.000563	0.0038	CcSEcCtD
Efavirenz—Mediastinal disorder—Thalidomide—leprosy	0.000562	0.00379	CcSEcCtD
Efavirenz—Arrhythmia—Thalidomide—leprosy	0.000557	0.00376	CcSEcCtD
Efavirenz—Alopecia—Thalidomide—leprosy	0.000551	0.00372	CcSEcCtD
Efavirenz—Vomiting—Dapsone—leprosy	0.00055	0.00371	CcSEcCtD
Efavirenz—Malnutrition—Thalidomide—leprosy	0.000543	0.00366	CcSEcCtD
Efavirenz—Headache—Dapsone—leprosy	0.000542	0.00366	CcSEcCtD
Efavirenz—Flatulence—Thalidomide—leprosy	0.000535	0.00361	CcSEcCtD
Efavirenz—Tension—Thalidomide—leprosy	0.000532	0.0036	CcSEcCtD
Efavirenz—Dysgeusia—Thalidomide—leprosy	0.000531	0.00359	CcSEcCtD
Efavirenz—Nervousness—Thalidomide—leprosy	0.000527	0.00356	CcSEcCtD
Efavirenz—Back pain—Thalidomide—leprosy	0.000525	0.00355	CcSEcCtD
Efavirenz—Nausea—Dapsone—leprosy	0.000514	0.00347	CcSEcCtD
Efavirenz—Vision blurred—Thalidomide—leprosy	0.000511	0.00345	CcSEcCtD
Efavirenz—Tremor—Thalidomide—leprosy	0.000508	0.00343	CcSEcCtD
Efavirenz—Ill-defined disorder—Thalidomide—leprosy	0.000503	0.0034	CcSEcCtD
Efavirenz—Anaemia—Thalidomide—leprosy	0.000502	0.00339	CcSEcCtD
Efavirenz—Agitation—Thalidomide—leprosy	0.000499	0.00337	CcSEcCtD
Efavirenz—Angioedema—Thalidomide—leprosy	0.000496	0.00335	CcSEcCtD
Efavirenz—Malaise—Thalidomide—leprosy	0.000489	0.0033	CcSEcCtD
Efavirenz—Vertigo—Thalidomide—leprosy	0.000488	0.00329	CcSEcCtD
Efavirenz—Syncope—Thalidomide—leprosy	0.000487	0.00329	CcSEcCtD
Efavirenz—Palpitations—Thalidomide—leprosy	0.00048	0.00324	CcSEcCtD
Efavirenz—Loss of consciousness—Thalidomide—leprosy	0.000477	0.00322	CcSEcCtD
Efavirenz—Cough—Thalidomide—leprosy	0.000474	0.0032	CcSEcCtD
Efavirenz—Convulsion—Thalidomide—leprosy	0.00047	0.00318	CcSEcCtD
Efavirenz—Hypertension—Thalidomide—leprosy	0.000468	0.00316	CcSEcCtD
Efavirenz—Arthralgia—Thalidomide—leprosy	0.000462	0.00312	CcSEcCtD
Efavirenz—Chest pain—Thalidomide—leprosy	0.000462	0.00312	CcSEcCtD
Efavirenz—Myalgia—Thalidomide—leprosy	0.000462	0.00312	CcSEcCtD
Efavirenz—Anxiety—Thalidomide—leprosy	0.00046	0.00311	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000459	0.0031	CcSEcCtD
Efavirenz—Discomfort—Thalidomide—leprosy	0.000456	0.00308	CcSEcCtD
Efavirenz—Dry mouth—Thalidomide—leprosy	0.000452	0.00305	CcSEcCtD
Efavirenz—Confusional state—Thalidomide—leprosy	0.000447	0.00302	CcSEcCtD
Efavirenz—Shock—Thalidomide—leprosy	0.000436	0.00294	CcSEcCtD
Efavirenz—Nervous system disorder—Thalidomide—leprosy	0.000434	0.00293	CcSEcCtD
Efavirenz—Thrombocytopenia—Thalidomide—leprosy	0.000434	0.00293	CcSEcCtD
Efavirenz—Tachycardia—Thalidomide—leprosy	0.000432	0.00292	CcSEcCtD
Efavirenz—Skin disorder—Thalidomide—leprosy	0.00043	0.00291	CcSEcCtD
Efavirenz—Hyperhidrosis—Thalidomide—leprosy	0.000428	0.00289	CcSEcCtD
Efavirenz—Anorexia—Thalidomide—leprosy	0.000422	0.00285	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Thalidomide—leprosy	0.000403	0.00273	CcSEcCtD
Efavirenz—Insomnia—Thalidomide—leprosy	0.000401	0.00271	CcSEcCtD
Efavirenz—Paraesthesia—Thalidomide—leprosy	0.000398	0.00269	CcSEcCtD
Efavirenz—Dyspnoea—Thalidomide—leprosy	0.000395	0.00267	CcSEcCtD
Efavirenz—Somnolence—Thalidomide—leprosy	0.000394	0.00266	CcSEcCtD
Efavirenz—Dyspepsia—Thalidomide—leprosy	0.00039	0.00263	CcSEcCtD
Efavirenz—Decreased appetite—Thalidomide—leprosy	0.000385	0.0026	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Thalidomide—leprosy	0.000382	0.00258	CcSEcCtD
Efavirenz—Fatigue—Thalidomide—leprosy	0.000382	0.00258	CcSEcCtD
Efavirenz—Constipation—Thalidomide—leprosy	0.000379	0.00256	CcSEcCtD
Efavirenz—Pain—Thalidomide—leprosy	0.000379	0.00256	CcSEcCtD
Efavirenz—Feeling abnormal—Thalidomide—leprosy	0.000365	0.00246	CcSEcCtD
Efavirenz—Gastrointestinal pain—Thalidomide—leprosy	0.000362	0.00245	CcSEcCtD
Efavirenz—Urticaria—Thalidomide—leprosy	0.000352	0.00238	CcSEcCtD
Efavirenz—Body temperature increased—Thalidomide—leprosy	0.00035	0.00236	CcSEcCtD
Efavirenz—Abdominal pain—Thalidomide—leprosy	0.00035	0.00236	CcSEcCtD
Efavirenz—Hypersensitivity—Thalidomide—leprosy	0.000326	0.0022	CcSEcCtD
Efavirenz—Asthenia—Thalidomide—leprosy	0.000318	0.00215	CcSEcCtD
Efavirenz—Pruritus—Thalidomide—leprosy	0.000313	0.00212	CcSEcCtD
Efavirenz—Diarrhoea—Thalidomide—leprosy	0.000303	0.00205	CcSEcCtD
Efavirenz—Dizziness—Thalidomide—leprosy	0.000293	0.00198	CcSEcCtD
Efavirenz—Vomiting—Thalidomide—leprosy	0.000282	0.0019	CcSEcCtD
Efavirenz—Rash—Thalidomide—leprosy	0.000279	0.00189	CcSEcCtD
Efavirenz—Dermatitis—Thalidomide—leprosy	0.000279	0.00188	CcSEcCtD
Efavirenz—Headache—Thalidomide—leprosy	0.000277	0.00187	CcSEcCtD
Efavirenz—Nausea—Thalidomide—leprosy	0.000263	0.00178	CcSEcCtD
